Home » Topics » Medical technology

Medical technology
RSS

Caution is urged in use of DES following myocardial infarction

Sep. 5, 2007

Celera to acquire BHL for $195M, no word on split from Applera

Sep. 5, 2007

Immutep Tests Lead Compound ImmuFact IMP321 In Melanoma

Sep. 5, 2007

Other News To Note

Sep. 5, 2007

Generic Epoetin Products Win Approval From EU

Sep. 5, 2007

By Peter O'Donnell

Forest Terminates Interest In Paion's Desmoteplase

Sep. 5, 2007

By Cormac Sheridan

Jerini Goes Solo With Icatibant In U.S. As Abbott Walks Out

Sep. 5, 2007

By Cormac Sheridan

Trophos Raises €8.5M To Move Compound Into Phase II Trials

Sep. 5, 2007

By James Etheridge

Heptares Spun Out of MRC To Become A Standalone

Sep. 5, 2007

Other News To Note

Sep. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...